Search Results - "Walker, Patricia A." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial

Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial

by Kerem, Eitan, Konstan, Michael W, De Boeck, Kris, Accurso, Frank J, Sermet-Gaudelus, Isabelle, Wilschanski, Michael, Elborn, J Stuart, Melotti, Paola, Bronsveld, Inez, Fajac, Isabelle, Malfroot, Anne, Rosenbluth, Daniel B, Walker, Patricia A, McColley, Susanna A, Knoop, Christiane, Quattrucci, Serena, Rietschel, Ernst, Zeitlin, Pamela L, Barth, Jay, Elfring, Gary L, Welch, Ellen M, Branstrom, Arthur, Spiegel, Robert J, Peltz, Stuart W, Ajayi, Temitayo, Rowe, Steven M
Published in The lancet respiratory medicine (01.07.2014)

Get more information

Journal Article

$Bortezomib-based antibody depletion for refractory autoimmune hematological diseases$

Bortezomib-based antibody depletion for refractory autoimmune hematological diseases

by Ratnasingam, Sumita, Walker, Patricia A., Tran, Huy, Kaplan, Zane S., McFadyen, James D., Tran, Huyen, Teh, Tse-Chieh, Fleming, Shaun, Catalano, John V., Chunilal, Sanjeev D., Johnston, Anna, Opat, Stephen S., Shortt, Jake
Published in Blood advances (29.11.2016)

Get full text

Journal Article

Center-level self-study identifies opportunities to advance equity in cystic fibrosis clinical trial participation

Center-level self-study identifies opportunities to advance equity in cystic fibrosis clinical trial participation

by Januska, Megan N, Langfelder-Schwind, Elinor, Plachta, Amy, Demarco, Teresa, Walker, Patricia A, Berdella, Maria N
Published in Journal of cystic fibrosis (01.07.2023)

Get full text

Journal Article

The CFTR variant profile of Hispanic patients with cystic fibrosis: Impact on access to effective screening, diagnosis, and personalized medicine

by Januska, Megan N., Marx, Laura, Walker, Patricia A., Berdella, Maria N., Langfelder‐Schwind, Elinor
Published in Journal of genetic counseling (01.08.2020)

Get full text

Journal Article

Unilateral internal jugular venous thrombosis in a young trauma patient

Unilateral internal jugular venous thrombosis in a young trauma patient

by Ackland, Helen M, Marshall, Nina L, Hall, Nicholas D.P, Walker, Patricia A, Varma, Dinesh K
Published in Injury extra (01.11.2009)

Get full text

Journal Article

Acalabrutinib ± Obinutuzumab Vs Obinutuzumab + Chlorambucil in Treatment-Naive Chronic Lymphocytic Leukemia: 6-Year Follow-up of Elevate-TN

Acalabrutinib ± Obinutuzumab Vs Obinutuzumab + Chlorambucil in Treatment-Naive Chronic Lymphocytic Leukemia: 6-Year Follow-up of Elevate-TN

by Sharman, Jeff P., Egyed, Miklos, Jurczak, Wojciech, Skarbnik, Alan, Patel, Krish, Flinn, Ian W., Kamdar, Manali, Munir, Talha, Walewska, Renata, Hughes, Marie, Fogliatto, Laura Maria, Herishanu, Yair, Banerji, Versha, Follows, George, Walker, Patricia A., Karlsson, Karin, Ghia, Paolo, Janssens, Ann, Cymbalista, Florence, Byrd, John C., Ferrant, Emmanuelle, Ferrajoli, Alessandra, Wierda, William G., Munugalavadla, Veerendra, Wachira, Catherine Wangui, Wun, Chuan-Chuan, Woyach, Jennifer A.
Published in Blood (02.11.2023)

Get full text

Journal Article

A 2-Stage Phase II Study of Panobinostat Consolidation in Multiple Myeloma (MM) Patients with < CR Following Single High-Dose Chemotherapy (HDT) Conditioned Autologous Stem Cell Transplantation (ASCT) As Part of First Line Therapy

A 2-Stage Phase II Study of Panobinostat Consolidation in Multiple Myeloma (MM) Patients with < CR Following Single High-Dose Chemotherapy (HDT) Conditioned Autologous Stem Cell Transplantation (ASCT) As Part of First Line Therapy

by Kalff, Anna, Mithraprabhu, Sridurga, Khong, Tiffany T., Ramachandran, Malarmathy, Reed, Kate, Quach, Hang, Walker, Patricia A., Bergin, Krystal, Spencer, Andrew
Published in Blood (02.12.2016)

Get full text

Journal Article

Post-Allogeneic Stem Cell Transplant Surveillance of CD34+ Sorted Peripheral Blood to Quantify Emergent DNMT3A, IDH and NPM1 clones and Correlation with Clinical Outcome

Post-Allogeneic Stem Cell Transplant Surveillance of CD34+ Sorted Peripheral Blood to Quantify Emergent DNMT3A, IDH and NPM1 clones and Correlation with Clinical Outcome

by Fleming, Shaun, Cummings, Nik, Das, Tongted, Ivey, Adam, McManus, Julie, Avery, Sharon, Patil, Sushrut S., Walker, Patricia A., Curtis, David J., Spencer, Andrew, Wei, Andrew
Published in Blood (08.12.2017)

Get full text

Journal Article

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

by Dimopoulos, Meletios A, Richardson, Paul G, Bahlis, Nizar J, Grosicki, Sebastian, Cavo, Michele, Beksaç, Meral, Legieć, Wojciech, Liberati, Anna M, Goldschmidt, Hartmut, Belch, Andrew, Magen, Hila, Larocca, Alessandra, Laubach, Jacob P, Petrucci, Maria T, Reece, Donna, White, Darrell, Mateos, María-Victoria, Špička, Ivan, Lazaroiu, Mihaela, Berdeja, Jesús, Kaufman, Jonathan L, Jou, Ying-Ming, Ganetsky, Alex, Popa McKiver, Mihaela, Lonial, Sagar, Weisel, Katja
Published in The Lancet. Haematology (01.06.2022)

Get more information

Journal Article

High Risk Multiple Myeloma: Better Outcomes with Upfront Tandem Autologous- Non-Myelo Ablative Allogeneic Stem Cell Transplantation Compared to Upfront Autologous Stem Cell Transplantation

High Risk Multiple Myeloma: Better Outcomes with Upfront Tandem Autologous- Non-Myelo Ablative Allogeneic Stem Cell Transplantation Compared to Upfront Autologous Stem Cell Transplantation

by Nair, Anish Puliyayil, Lee, Cindy, Kalff, Anna, Walker, Patricia A., Bergin, Krystal, Hocking, Jay, Morgan, Sue, Klarica, Daniela, Muirhead, Jenny, Spencer, Andrew, Lee, Oi Lin, Horvath, Noemi
Published in Blood (02.12.2016)

Get full text

Journal Article

Comparison of Cyclophosphamide/Total Body Irradiation (Cy/TBI) and Etoposide/Total Body Irradiation (Etop/TBI) Conditioned Allogeneic Stem Cell Transplant (alloHSCT) for Adult Acute Lymphoblastic Leukaemia (ALL), Data from an Australian Tertiary Care Centre

Comparison of Cyclophosphamide/Total Body Irradiation (Cy/TBI) and Etoposide/Total Body Irradiation (Etop/TBI) Conditioned Allogeneic Stem Cell Transplant (alloHSCT) for Adult Acute Lymphoblastic Leukaemia (ALL), Data from an Australian Tertiary Care Centre

by Nair, Anish Puliyayil, Fleming, Shaun, Avery, Sharon, Curtis, David J., Patil, Sushrut S., Walker, Patricia A., Wei, Andrew, Muirhead, Jenny, Spencer, Andrew
Published in Blood (03.12.2015)

Get full text

Journal Article

Autologous Stem Cell Transplantation (ASCT) Followed By Outpatient-Based Non-Myeloblative Allogeneic (NMA) Stem Cell Transplantation (Tandem Auto-Allo) for Biologically Adverse Multiple Myeloma (MM). a Single Centre Experience from Australia

Autologous Stem Cell Transplantation (ASCT) Followed By Outpatient-Based Non-Myeloblative Allogeneic (NMA) Stem Cell Transplantation (Tandem Auto-Allo) for Biologically Adverse Multiple Myeloma (MM). a Single Centre Experience from Australia

by Nair, Anish Puliyayil, Walker, Patricia A., Kalff, Anna, Bergin, Krystal, Avery, Sharon, Curtis, David J., Patil, Sushrut S., Muirhead, Jenny, Phomoonna, Tongted, Klarica, Daniela, Spencer, Andrew
Published in Blood (03.12.2015)

Get full text

Journal Article

$Bortezomib Yields High Response Rates in Antibody-Mediated Autoimmune Hematological Diseases Refractory to Conventional Immunosuppression$

Bortezomib Yields High Response Rates in Antibody-Mediated Autoimmune Hematological Diseases Refractory to Conventional Immunosuppression

by Ratnasingam, Sumita, Walker, Patricia A., Tran, Huy, Kaplan, Zane, McFadyen, James David, Tran, Huyen, Teh, Tse-Chieh, Wood, Erica M., Catalano, John V., Opat, Stephen, Shortt, Jake
Published in Blood (03.12.2015)

Get full text

Journal Article

Outpatient Non-Myeloablative Allogeneic Stem Cell Transplantation For Myeloma Is Feasible, Efficacious and Associated With Low Transplant-Related Morbidity and Mortality

Outpatient Non-Myeloablative Allogeneic Stem Cell Transplantation For Myeloma Is Feasible, Efficacious and Associated With Low Transplant-Related Morbidity and Mortality

by Campbell, Philip, Walker, Patricia A., Avery, Sharon, Patil, Sushrut S., Curtis, David J., Schwarer, Anthony P., Wei, Andrew H, Kalff, Anna, Muirhead, Jenny, Spencer, Andrew
Published in Blood (15.11.2013)

Get full text

Journal Article

Incidence and Kinetics Of Full Donor Chimerism and The Impact Of Minimal Residual Disease Status Following Outpatient Non-Myeloablative Allogeneic Stem Cell Transplantation For Myeloma

Incidence and Kinetics Of Full Donor Chimerism and The Impact Of Minimal Residual Disease Status Following Outpatient Non-Myeloablative Allogeneic Stem Cell Transplantation For Myeloma

by Campbell, Philip, Das, Tongted, Kipp, David, Walker, Patricia A., Muirhead, Jenny, Avery, Sharon, Patil, Sushrut S., Curtis, David J., Schwarer, Anthony P., Kalff, Anna, Spencer, Andrew
Published in Blood (15.11.2013)

Get full text

Journal Article

Leopard: A Phase II Study of Maintenance Lenalidomide and Prednisolone Post Autologous Stem Cell Transplantation (ASCT) for Myeloma, Incorporating Minimal Residual Disease Assessments

Leopard: A Phase II Study of Maintenance Lenalidomide and Prednisolone Post Autologous Stem Cell Transplantation (ASCT) for Myeloma, Incorporating Minimal Residual Disease Assessments

by Kalff, Anna, Kennedy, Nola, Walker, Patricia A., Khong, Tiffany T., Schwarer, Anthony, Roberts, Andrew W., Campbell, Philip, Filshie, Robin, Smiley, Angela, Gorniak, Malgorzata, Black, Marion, Jenkins, Nicole, Raines, Geoffrey, Spencer, Andrew
Published in Blood (06.12.2014)

Get full text

Journal Article

Leopard: A Phase II Study Of Post Autologous Stem Cell Transplantation (ASCT) Maintenance Lenalidomide and Prednisolone For Myeloma (MM), Incorporating Minimal Residual Disease (MRD) Assessments

Leopard: A Phase II Study Of Post Autologous Stem Cell Transplantation (ASCT) Maintenance Lenalidomide and Prednisolone For Myeloma (MM), Incorporating Minimal Residual Disease (MRD) Assessments

by Kalff, Anna, Kennedy, Nola, Walker, Patricia A., Black, Marion, Youdell, Odette, Gorniak, Malgorzata, Khong, Tiffany T., Estifo, Lona, Smiley, Angela, Schwarer, Anthony P., Roberts, Andrew W., Campbell, Philip, Flishie, Robin, Spencer, Andrew
Published in Blood (15.11.2013)

Get full text

Journal Article

Nursing ethics in stem cell research: Perceived attitudes and beliefs of nurses

Nursing ethics in stem cell research: Perceived attitudes and beliefs of nurses

by Walker, Patricia A
Year of Publication 01.01.2016

Get full text

Dissertation

Initial Remission Duration Is the Most Important Predictor of Outcome Following FLAG-Amsacrine Salvage of AML in First Relapse

Initial Remission Duration Is the Most Important Predictor of Outcome Following FLAG-Amsacrine Salvage of AML in First Relapse

by Fong, Chun Yew, Grigoriadis, George, Hocking, Jay, Campbell, Philip, Schwarer, Anthony P., Walker, Patricia A., Avery, Sharon, Patil, Sushrut S., Salem, Hatem H., Spencer, Andrew, Wei, Andrew H
Published in Blood (18.11.2011)

Get full text

Journal Article

$Azacitidine in Combination with the mTOR Inhibitor Everolimus in Relapsed and Refractory AML$

Azacitidine in Combination with the mTOR Inhibitor Everolimus in Relapsed and Refractory AML

by Wei, Andrew H, Tan, Peter T., Catalano, John, Walker, Patricia A., Schwarer, Anthony P., Avery, Sharon, Patil, Sushrut S., Opat, Stephen, Cummings, Nik, Spencer, Andrew
Published in Blood (18.11.2011)

Get full text

Journal Article